Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sona NanotechSNANF -22.65%26 Market Cap is $29.53 Mil as of Aug. 16, 2026. GuruFocus rates SNANF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 1,423 Biotechnology companies, Sona Nanotech ranks worse than 71.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sona Nanotech's share price for the quarter that ended in Apr. 2026 was $0.2233. Sona Nanotech's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 114.38 Mil. Therefore, Sona Nanotech's market cap for the quarter that ended in Apr. 2026 was $25.54 Mil.
Sona Nanotech's quarterly market cap
declined
from Oct. 2025 ($50.80 Mil) to Jan. 2026 ($33.53 Mil) and
declined
from Jan. 2026 ($33.53 Mil) to Apr. 2026 ($25.54 Mil).
Sona Nanotech's annual market cap
increased
from Oct. 2023 ($12.33 Mil) to Oct. 2024 ($21.79 Mil) and
increased
from Oct. 2024 ($21.79 Mil) to Oct. 2025 ($50.80 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sona Nanotech's Enterprise Value for Today is $29.73 Mil.
Sona Nanotech (OTCPK:SNANF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sona Nanotech Market Cap Related Terms
Sona Nanotech Market Cap Historical Data
* Premium members only.
The historical data trend for Sona Nanotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Sona Nanotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sona Nanotech Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sona Nanotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Sona Nanotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sona Nanotech's Market Cap for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sona Nanotech (SNANF) has a Market Cap of $29.53 Mil as of Aug. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sona Nanotech and its competitors. According to the industry distribution chart, Sona Nanotech ranks #1014 out of 1423 companies in the Biotechnology industry, placing it in the top 71.3%.
Is Sona Nanotech's Market Cap too high?
Sona Nanotech's current Market Cap is $29.53 Mil. The Biotechnology industry median Market Cap is 118.89. Sona Nanotech's value of $29.53 Mil is 75.2% below this industry median. Based on the distribution chart, Sona Nanotech ranks #1014 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sona Nanotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Sona Nanotech's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sona Nanotech ranks #1014 out of 1423 companies for Market Cap. This places Sona Nanotech in the lower half of its industry. The industry median Market Cap is 118.89. Sona Nanotech's value of $29.53 Mil is 75.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 118.89, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sona Nanotech's current Market Cap of $29.53 Mil is 75.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sona Nanotech and its competitors. For the Biotechnology industry, the median Market Cap is 118.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sona Nanotech's current Market Cap is $29.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sona Nanotech stock overvalued right now?
Sona Nanotech (SNANF) has a current Market Cap of $29.53 Mil. The current Market Cap is $29.53 Mil and 75.2% below the Biotechnology industry median of 118.89. Sona Nanotech's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sona Nanotech (SNANF), the current Market Cap is $29.53 Mil as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sona Nanotech Inc is involved in the nanotechnology life sciences industry. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles and is engaged in the research and development of its proprietary technology for use in biomedical applications and multiplex diagnostic testing platforms. The company is using its gold nano rods manufacturing technology to develop new products and methods for cancer treatment, including a Targeted Hyperthermia Therapy (THT). Additionally, it has filed patent applications in the U.S. regarding a gold nanorod conjugation concept for targeted drug delivery, combination therapies for treating cancer, and for an endoscope with an optical fibre and thermal sensor for photothermal therapy.
26GF Score
Get the complete analysis for SNANF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNANF has been successfully added to your 
